Human endogenous retroviruses (HERVs) are widely believed to be remnants of 
are estimated to comprise more than 8% of the human genome. of the coding genes in HERVs have been degraded by deletions or mutations during evolution as part of the human genome, 3 and only very few of them retain all structural features necessary for viral replication. 4 In contrast to the coding genes, many HERV LTRs retain their potential to regulate gene transcription with the viral promoter, enhancer, and polyadenylation signals. 5 Physiological expression of HERV-H elements has been observed in embryonic stem cells. 5, 6 The placenta has some peculiarities in the expression of all kinds of HERVs, 1,2 for which lower methylation content in the genome and some unique properties in epigenetic gene regulation may contribute to this phenomenon. 4 However, in more circumstances, aberrant expression of HERVs is associated with a wide range of diseases, including cancers, fetal malformations, and autoimmune diseases. [7] [8] [9] [10] HERVs have been investigated in a large number of autoimmune disorders due to their role in innate and adaptive immunity based on molecular mimicry. 11 Multiple sclerosis-associated retrovirus (MSRV) might have originated from the recombination of different HERV-W transcripts, 12 which was associated with poor prognosis in patients with multiple sclerosis and a higher rate of clinical reexacerbations. [13] [14] [15] Syncytin-1, a HERV-W env protein, has been found to regulate neuroinflammation in multiple sclerosis. 16 HERV-W env gene products have also been detected in plasma of schizophrenia and bipolar disorders patients. 17, 18 Recently, Levet et al demonstrated that HERV-W env expression was significantly upregulated in patients suffering from type 1 diabetes, 19 suggesting new therapies for type 1 diabetes. 20 Besides HERV-W, single-nucleotide polymorphisms (SNPs)
around HERV-Fc1 showed a highly significant association with multiple sclerosis. 21 HERV-H/env59 protein was found to be upregulated in patients with systemic lupus erythematosus and negatively correlated with pathogenetic factors of human autoimmune rheumatic diseases. 22 Aberrant expression of various HERVs has been demonstrated in human cancer cell lines and primary tumor tissues, such as HERV-H, 23 HERV-K, 24 HERV-F, 25 HERV-R, 26 and HERV-S. 27 Rooney et al systematically mapped the RNA sequencing data from 18 different types of solid tumors to 66 HERV family members and identified numerous
HERVs to show enhanced transcription in tumor tissues as compared with normal tissues. 28, 29 Among them, a conservative set of three tumor-specific endogenous retroviruses (HERVH-5, HERVH48-1, and HERVE-4) all showed minimal to undetectable expression in normal tissues and elevated expression in tumor tissues. Another array-based study demonstrated that numerous HERV family members exhibited lower levels of DNA methylation in head and neck cancers as compared with adjacent nontumor tissues, with the most pronounced changes in methylation levels observed in HERV-H, HERV-W, and HERV-K families. 30 Due to the hypomethylation status of CpG dinucleotides, high expression of HERV-K gag gene, LINE-1, and HERV-W was detected in ovarian cancer cell lines and tumor tissues. [31] [32] [33] Moreover, the methylation levels of HERV-K, HERV-E, and LINE-1 were found to be decreased during ovarian cancer progression. 34 However, the pathogenic roles and mechanisms of HERVs in cancers remain elusive. Further investigations on individual families of HERVs are also warranted. The transcriptional analysis of specific HERV-H copies is challenging due to the high similarity among the 1000 members of the HERV-H family distributing throughout the human genome. However, there are still a variety of researches focusing on the expressional activation, especially the noncoding spliced transcripts, of HERV-H elements. In another study, we characterized the expression of noncoding spliced transcripts of HERV-H elements in colon cancer using a targeted PCR and cloning strategy. 44 We observed that many env- 
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| Other HERV families in cancers
Besides HERV-H, expression of various HERVs has been demonstrated in human cancer cell lines and primary tumor tissues, such as HERV-K, 24, 47, 48 HERV-W, 47 HERV-F, 25 HERV-R, 26 and HERV-S. 27 Among these, the HERV-K family is remarkable since many of them still retain oncogene by PLZF and ultimately promoting cell proliferation. 51 Zhao et al observed that the HERV-K env protein was expressed in the majority of primary breast tumors. 52 Furthermore, HERV-K antibodies and mRNA are elevated in blood of patients at an early stage of breast cancer and further increased in patients who are at risk of developing metastatis. 53 An in vitro experiment showed that HERV-K env protein effectively activated the ERK1/2 pathway and induced epithelialmesenchymal transition in a nontumorigenic human breast epithelial cell line, suggesting that this HERV-K env protein has oncogenic properties. 54 Moreover, HERV-K expression was significantly associated with poor outcome in hepatocellular carcinoma patients, 55 as well as cancer progression in soft tissue sarcoma. 56 Elevated HERV-K gag expression in PBMC was associated with prostate cancer diagnosis particularly in older men and smokers who tend to develop a more aggressive disease. 57 Recently, HERV-K env expression was detected in pancreatic cancer cell lines and in 80% of pancreatic cancer patient biopsies, but not in normal pancreatic cell lines or uninvolved normal tissues. 58 The significantly elevated expression of numerous HERV elements in various cancers has accelerated their use as biomarkers for cancer aggressiveness and malignancy.
| REGULATORY MECHANISMS OF HERV EXPRESSION
The human host has developed a long-standing relationship with 67 Therefore, HERV expression may be activated not only by viruses but also by other infectious agents.
| Activation of HERVs by external factors
However, the specific microbial species affecting HERV expression and the relevant mechanism need to be elucidated in further studies.
| Activation of HERVs by host factors
Besides the activation by external factors, HERV expression is also regulated by host factors during cellular processes. Epigenetic mechanisms including DNA methylation and histone modifications, 68 regulatory proteins such as transcription factors, 69 cytokines, 70 and small 70 The important role for small RNAs (such as Piwi-interacting small RNA) in silencing ERVs via homology-dependent mechanisms has been confirmed in mouse. 73, 83 However, the role of small RNAs in regulating the expression of HERVs in human needs further investigation.
| FUNCTIONAL ROLES OF HERVs IN CARCINOGENESIS
The 
| Noncoding RNA transcripts
Due to the accumulated deletions and mutations in the viral protein
ORFs during evolution as parts of the human genome, most of the HERVs are transcriptionally silenced or may only produce noncoding RNA (ncRNA) transcripts. Kelley and Rinn found a close association between HERVs and ncRNAs and identified 127 ncRNAs originating from HERVs. 84 They believed that HERV-Hs were responsible for the birth of new ncRNAs by inserting active promoters into previously inactive genomic regions. The long ncRNA ROR, with emerging roles being found in human cancers, 85, 86 was one of the ncRNAs promoted by a HERV-H element. 87 The ncRNAs from HERVs have various potential to affect genome functions; some of the effects may benefit the host, while others may be pathogenic. 88, 89 The protein PSF (polypyrimidine tract-binding protein-associated splicing factor) functions to repress protooncogene transcription. 90 The ncRNA produced by a HERV-K11 provirus binds to PSF directly, reversing the PSF-mediated repression of proto-oncogene transcription and subsequently driving transformation and tumorigenesis. was observed to be driven by an aberrantly activated LTR promoter to express in Hodgkin lymphoma, 100 suggesting that activation of the usually silenced repeat elements may play a role in the pathogenesis of human malignancies. An LTR element of HERV-H with reverse orientation has been identified as an alternative promoter of the GSDML (gasdermin-like protein) gene, 101 which is located near an oncogenomic recombination hotspot. 102 The GSDML transcripts derived from this LTR promoter were widely distributed in various human tissues and cancer cells. HERV-H LTRs also appeared to function as enhancers for pluripotency-related genes. 6 Therefore, by serving as promoters or providing transcriptional regulatory sites, LTRs participate in regulating cellular gene expression and may affect carcinogenesis when cancer-related genes are regulated.
| Transcriptional regulation of adjacent genes by LTR
| HERV-mediated nonallelic homologous recombination
HERV families contain a large number of long and highly homogeneous copies, providing an ideal substrate for nonallelic homologous recombination between members that are located on the same or different chromosomes. A systematic phylogenetic sequence analysis on the most recently active HERV members showed evidence for HERVmediated genomic rearrangements during primate evolution; at least 16% of these elements had undergone apparent rearrangements.
108
HERV elements throughout the genome have been shown to serve as substrates for genomic instability and mediate human copy-number variation. 109 Nonallelic homologous recombination may result in chromosomal anomalies that are ubiquitous in cancers, including translocations, duplications, deletions, inversions, and rearrangements. Tomlins et al 110 found a fusion between a HERV-K provirus and a dormant oncogene of the E26 transformation-specific family in human prostate cancer. A recurrent translocation was identified to be mediated by homologous recombination between HERV-H elements on chromosomes 4 and 18 in children with intellectual disability. 111 In one of the most serious radiological accidents occurred at a radiation therapy unit in Brazil, nonallelic recombination between two HERVs, caused by exposure to ionizing radiations, contributed to chromosomal rearrangements in the AZF region in patients. 112 More systematic analyses are needed to elucidate the importance of HERV-mediated rearrangements during carcinogenesis.
| HERV-mediated insertional mutagenesis
Exogenous infectious retroviruses-mediated insertional mutagenesis can led to the activation of cellular oncogenes or disruption of tumor-suppressor genes. 113 Some ERVs retaining infectivity may share the transforming potential. The role of infectious copies of mouse mammary tumor virus (MMTV) or murine leukemia virus (MLV) has been well studied in the insertional activation of oncogenes (Wnt1 and Notch4) and disruption of tumor suppressor genes in mice. 114 The strong link between MMTV infection and mammary tumorigenesis in mice leads to a hypothesis for retroviruses in causing human cancers. Some researchers have succeeded in reconstituting the human-specific active HERV-K provirus, 115, 116 indicating that human cells still have the potential to produce infectious retroviruses.
Although these reconstituted viral particles are not highly infectious and no infectious HERV-derived retrovirus has been discovered in vivo until now, these studies support the hypothesis regarding the potential oncogenic mechanism of insertional mutagenesis by an infectious HERV.
| HERV-mediated cell fusion
The most well-known physiological role of HERV is that of the Syncytin-1 protein, encoded by HERV-W, in mediating trophoblast fusion. 117 Syncytin-1 expression on the surface of cytotrophoblasts and syncytiotrophoblasts mediates fusion; this cell-cell fusion is essential for normal placental development. 118 Recently, another HERV-FRD-derived protein, syncytin-2, was identified and shown to be sufficient for mediating cell fusion. 119, 120 Besides mediating trophoblast fusion, the HERV protein syncytins have recently been found to mediate cell-to-cell transfer of mitochondria. Mitochondria are crucial organelles that regulate not only the energy metabolism but also the survival and fate of eukaryotic cells. 
| Regulation of innate immunity by HERVs
The ability of HERVs in regulating the immune system may have opposite effects on cancer development, relevant to both oncogenic processes and anticancer defenses. Some HERV-env proteins have been shown to exert immunosuppressive properties, such as the human syncytin-2. 129 Cianciolo et al also reported that some ERV-env pro- appears to be bidirectional transcription of HERVs that are known to fold into dsRNA secondary structures. 140 Chuong et al also found that
HERVs played a crucial role in the transcriptional network underlying IFN response and induced innate immunity, and the expression of IFN-induced genes was significantly decreased after the CRISPR-Cas9 deletion of these HERV elements in human genome. 
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